Cipla Ltd

Yes Bank, IndusInd to join India's BSE Sensex index; Lupin, Cipla dropped

Yes Bank, IndusInd to join India's BSE Sensex index; Lupin, Cipla dropped

Drugmakers Lupin Ltd and Cipla Ltd will make way for the two banks, according to a statement from Asia Index Pvt Ltd. 

Nov 17, 2017, 18:54 PM IST

Drug pricing: Don't take coercive steps against pharma companies, says HC

Delhi High Court today told the government not to take any coercive action against pharma companies, including Novartis India Limited and Cipla Ltd, in connection with the notices issued to them for allegedly not ensuring implementation of the revised drug pricing of 2013.

Nov 24, 2015, 21:19 PM IST

Cipla to buy two US generic drug firms for $550 million

Cipla Ltd said on Friday it has agreed to buy two generics businesses in the United States in an all-cash deals worth $550 million, as part of an effort to boost its presence in the world`s largest generics market.

Sep 04, 2015, 10:53 AM IST

Cipla shares end 5% lower on profit-booking

Shares of drug major Cipla Monday pared early gains on profit-booking, falling 5 percent, even as the company reported an over two-fold jump in consolidated net profit for the quarter ended June 30, 2015.

Aug 17, 2015, 22:58 PM IST

Cipla to pay $26 mn upfront for 51% stake in Ugandan firm

Drug major Cipla has re-negotiated payment terms for acquiring majority stake in Uganda's Quality Chemicals and now decided to pay USD 26 million (around Rs 166 crore) upfront to the shareholders of the African firm.

Jul 24, 2015, 23:37 PM IST

Lupin, Cipla bid for UCB's US generic drugs portfolio: Report

Generic drugmakers Lupin Ltd and Cipla Ltdare among the companies bidding for top Belgian drugmaker UCB SA`s U.S. generic drugs business, a leading dailey reported on Monday, citing unnamed people with knowledge of the matter.

Jun 01, 2015, 18:56 PM IST

Cipla Q3 Net up 15% at Rs 328 cr; to buy 60% in Jay Precision

Pharmaceutical firm Cipla Ltd on Thursday reported 15.31 percent increase in its consolidated net profit at Rs 327.85 crore in the third quarter ended December 31, 2014.

Feb 12, 2015, 21:56 PM IST

Cipla bags Rs 1,100 crore order from South African govt

Drug major Cipla's subsidiary has bagged an order worth 2 billion rand (around Rs 1,100 crore) for HIV drugs from the South African government.

Dec 23, 2014, 18:04 PM IST

Novartis sues India's Cipla over respiratory drug Onbrez

Swiss drugmaker Novartis AG said on Wednesday it had sued India`s Cipla Ltd for infringing patents covering its respiratory drug Onbrez, a month after Cipla launched a copy at a fifth of the original drug`s price.

Dec 17, 2014, 19:21 PM IST

Cipla seeks adoption of pragmatic IPR policy

Pharma major Cipla Ltd has sought adoption of a pragmatic Intellectual Property Rights (IPR) policy including in-licensing within the present framework of its international obligations.

Aug 17, 2014, 23:02 PM IST

UBS downgrades Cipla to ''sell''; shares fall

Shares of Cipla Ltd fall after UBS downgrades the stock to "sell" from "buy" and reduces its target to 370 rupees from 470 rupees citing "weak" earnings outlook despite "premium" valuations.

May 20, 2014, 11:46 AM IST

Cipla to pick 14.6% stake in Chase Pharmaceuticals for $1.5 mn

The investment will be done through Cipla's wholly owned subsidiary Cipla (EU) Ltd, UK.

May 12, 2014, 13:19 PM IST

Cipla ups stake in Ugandan firm, acquires 14.5% for $15 million

Pharma firm Cipla Ltd on Thursday said it has gained majority stake in Uganda-based Quality Chemical Industries Ltd with the acquisition of additional 14.5 per cent stake for USD 15 million.

Nov 21, 2013, 15:17 PM IST

Morgan Stanley downgrades Cipla to "underweight"

Morgan Stanley downgraded Cipla Ltd to "underweight" from "equal-weight" and reduces its target price on the stock to Rs 386 from Rs 414 citing slower growth prospects and valuations.

Aug 13, 2013, 14:57 PM IST

Drugs pricing row: HC extends relief to Cipla Ltd till Aug 27

Delhi High Court on Tuesday extended the operation of its earlier order asking the Centre not to take coercive steps against pharma major Cipla Ltd which was told to replace stocks in the market with those carrying reduced prices within 45 days of new price notification.

Jul 30, 2013, 19:22 PM IST

Cipla hopeful of achieving 12-15% revenue growth in FY13

Pharma major Cipla Ltd Thursday said it is hopeful of achieving 12-15 percent revenue growth in the current financial year.

Aug 17, 2012, 20:59 PM IST